Peritoneal Carcinomatosis A Multidisciplinary Approach /
Recent developments in regional and systemic anticancer therapies have improved the grim outlook of patients with peritoneal carcinomatosis (PC) from ovarian or gastrointestinal origin, leading to a renewed interest in both the underlying mechanisms at the origin of PC and the various therapeutic op...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Boston, MA :
Springer US,
2007.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Peritoneal Carcinomatosis: Basic Concepts
- Structure and Function of Mesothelial Cells
- Molecular Biology of Peritoneal Carcinomatosis
- Role of Adhesion Molecules in Locoregional Cancer Spread
- Surgical Trauma, Minimal Residual Disease and Locoregional Cancer Recurrence
- Pseudomyxoma Peritonei Syndrome: Classification of Appendiceal Mucinous Tumours
- The Pathogenesis of Malignant Ascites
- Natural History of Peritoneal Carcinomatosis from Digestive Origin
- The Rationale for Intraperitoneal Heat and Drug Therapy
- Intraperitoneal Drug Therapy: Physical and Biological Principles
- Current Status of Intraperitoneal Antineoplastic Drug Delivery
- The Biologic Rationale of Hyperthermia
- Interactions between Hyperthermia and Cytotoxic Drugs
- Pharmacodynamic Aspects of Intraperitoneal Cytotoxic Therapy
- Cytoreductive Surgery for Peritoneal Carcinomatosis: Techniques and Methods
- Patient Selection for Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion
- Staging and Scoring of Peritoneal Carcinomatosis
- Peritonectomy Procedures
- Continuous Peritoneal Perfusion: Techniques, Methods and Applications
- Handling of Chemotherapeutic Drugs in the OR: Hazards and Safety Considerations
- Clinical Results of Surgery with or without Intraperitoneal Heated Drug Therapy
- Results of Cytoreduction followed by HIPEC in Carcinomatosis of Colorectal Origin
- HIPEC with Oxaliplatin in the Treatment of Peritoneal Carcinomatosis of Colorectal Origin
- Clinical Results of Cytoreduction and HIPEC in Pseudomyxoma Peritonei
- The Impact of Therapy in the Treatment of Pseudomyxoma Peritonei
- Clinical Results of Cytoreduction and HIPEC for Malignant Peritoneal Mesothelioma
- Cytoreduction and Intraperitoneal Chemotherapy for Carcinomatosis from Gastric Cancer
- Cytoreduction and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Cancer
- The role of Neoadjuvant Chemotherapy versus Primary Surgery in the Management of Stage III Ovarian Cancer
- Morbidity and Quality of Life following Cytoreduction and HIPEC
- Detection and Treatment of Recurrent Disease after Cytoreduction and HIPEC
- Nonoperative and Multimodal Management of Peritoneal Carcinomatosis
- Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer
- Systemic Chemotherapy in patients with Peritoneal Carcinomatosis from Non Colorectal Origin
- The Role of Radiotherapy in the treatment of Peritoneal Carcinomatosis
- Medical and Palliative Management of Malignant Ascites
- Experimental Approaches
- Targeted Intraabdominal Chemotherapy for Peritoneal Carcinomatosis
- Immunotherapy of Peritoneal Carcinomatosis
- Intraperitoneal Photodynamic Therapy
- Intraperitoneal Gene Therapy.